Welcome to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
NB: We use cookies to help personalise your web experience and comply with Irish healthcare law. Whatever your choice, you are agreeing to our use of cookies. Please close this browser tab if you don't want to proceed.
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

October 9, 2015


Company: Clonmel Healthcare.
Legal category: Prescription. GMS. Sport permitted.
Active ingredient: Esomeprazole (as magnesium dihydrate) 20mg, 40mg.
Description: 20mg: Opaque yellow and white gastro-resistant hard capsule marked 20mg, containing off-white to greyish spherical microgranules. 40mg: Opaque yellow gastro-resistant hard capsule marked 40mg, containing off-white to greyish spherical microgranules.
Presentation: 20mg-28, €20.09; 40mg-28, €30.92.
Indications: Treatment of erosive reflux oesophagitis (RO); long-term management of healed oesophagitis to prevent relapse; symptomatic treatment of gastroesophageal reflux disease (GORD). In combination with appropriate antibacterial therapy: Healing of Helicobacter pylori associated duodenal ulcers; prevention of H. pylori associated peptic ulcers. Healing of gastric ulcers associated with NSAID therapy; prevention of NSAID associated gastric and duodenal ulcers in at risk patients. Prolonged treatment after IV induced prevention of rebleeding of peptic ulcers. Treatment of Zollinger Ellison syndrome (ZES).
Pharmacology: Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. Both the R- and S-isomer of omeprazole have similar pharmacodynamic activity. Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+K+-ATPase and inhibits both basal and stimulated acid secretion.
Dosage: Adult: Swallow whole with liquid. Erosive RO: Treatment, 40mg once daily for 4 weeks, double duration if not fully healed or symptoms persist. Prevention of relapse, 20mg once daily. GORD without oesophagitis: 20mg once daily until resolved. Maintenance, 20mg when required. H. pylori associated ulcers: Healing/prevention, 20mg with 1g amoxicillin and 500mg clarithromycin, all twice daily for 7 days. NSAID associated ulcers: Healing, 20mg once daily, duration 4-8 weeks. Prevention, 20mg once daily. Prolonged treatment after IV induced prevention of rebleeding of peptic ulcers: 40mg once daily for 4 weeks. ZES: Initially, 40mg twice daily. Usual range, 80-160mg daily. Doses above 80mg daily, divide and administer twice daily. Severe hepatic impairment: Maximum 20mg daily. Elderly: As per adults. Children: Above 12 years, RO and GORD only, as per adults. Under 12 years, not recommended.
Contraindications: Known hypersensitivity to esomeprazole, substituted benzimidazoles or any other constituents of the formulation. Lactation.
Special precautions: In gastric ulcer, exclude malignancy before treatment. Long-term treatment (monitor). Advise patients on on-demand treatment to report changes in their symptoms. Slightly increased risk of GI infections (Salmonella, Campylobacter). Renal insufficiency. Pregnancy. Contains sucrose and parahydroxybenzoates.
Drug interactions: Contraindicated: Nelfinavir. Not recommended: Atazanavir. Caution: Ketoconazole, itraconazole, CYP2C19 substrates (e.g. diazepam, citalopram, imipramine, clomipramine, phenytoin, voriconazole) and inhibitors, warfarin or other coumarin derivatives, cisapride, CYP3A4 inhibitors (clarithromycin).
Adverse drug reactions: Headache, abdominal pain, constipation, diarrhoea, flatulence, nausea/vomiting.
Full prescribing information and references available from Clonmel Healthcare. Telephone: (052) 6177777. Fax: (052) 6177791. E-mail: medicalinformation@clonmel-health.ie